Aug 2 (Reuters) - Kalytera Therapeutics Inc KALY.V :
* KALYTERA COMPLETES PRE-IND MEETING WITH FDA
* KALYTERA - DURING MEETING, FDA ASKED THAT CO ASSESS CERTAIN SAFETY AND LABORATORY PARAMETERS OF CBD
* KALYTERA THERAPEUTICS INC - PLANS TO INITIATE TWO CLINICAL STUDIES IN HEALTHY VOLUNTEERS THIS YEAR